Agios Pharmaceuticals Inc Revenue Y/Y
What is the Revenue Y/Y of Agios Pharmaceuticals Inc?
The Revenue Y/Y of Agios Pharmaceuticals Inc is 55.39%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with revenue y/y similar to Agios Pharmaceuticals Inc
- Tata Motors has Revenue Y/Y of 55.10%
- Tourism Finance of India has Revenue Y/Y of 55.14%
- Genesys International has Revenue Y/Y of 55.21%
- New Residential Investment Corp has Revenue Y/Y of 55.22%
- Trisura has Revenue Y/Y of 55.32%
- Wilmington Capital Management has Revenue Y/Y of 55.35%
- Agios Pharmaceuticals Inc has Revenue Y/Y of 55.39%
- Kings Infra Ventures has Revenue Y/Y of 55.44%
- Photon Control has Revenue Y/Y of 55.49%
- Lumax Industries has Revenue Y/Y of 55.51%
- Scholar Education has Revenue Y/Y of 55.51%
- Crestwood Equity Partners LP has Revenue Y/Y of 55.56%
- Geekay Wires has Revenue Y/Y of 55.61%